Back
Vanguard FTSE Developed Markets ETF Vs. Praxis Precision Medicines Industry Stock Comparison
Buy
56
VEA
Vanguard FTSE Developed Markets ETF
Last Price:
49.55
Seasonality Move:
0.5%
Sell
39
PRAX
Praxis Precision Medicines
Last Price:
54.82
Seasonality Move:
-37.1%
Buy
56
Vanguard FTSE Developed Markets ETF (VEA)
is a Buy
Is Vanguard FTSE Developed Markets ETF a Buy, Sell or Hold?
- The current Vanguard FTSE Developed Markets ETF [VEA] share price is $49.11. The Score for VEA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- VEA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Praxis Precision Medicines (PRAX)
is a Sell
Is Praxis Precision Medicines a Buy, Sell or Hold?
- The current Praxis Precision Medicines [PRAX] share price is $54.42. The Score for PRAX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PRAX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VEA Stock Price Chart
What is Vanguard FTSE Developed Markets ETF's stock price today?
-
The Vanguard FTSE Developed Markets ETF share price today is $49.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VEA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRAX Stock Price Chart
What is Praxis Precision Medicines's stock price today?
-
The Praxis Precision Medicines share price today is $54.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing selling pressure, which indicates risk of future bearish movement.
VEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 52.9 | Buy |
| Chaikin Money Flow: | 12064415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.23 - 49.71) | Buy |
| Bollinger Bands (100): | (47.14 - 49.42) | Buy |
PRAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 53.76 | Buy |
| Chaikin Money Flow: | -86259 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.48 - 56.28) | Buy |
| Bollinger Bands (100): | (29.95 - 55.61) | Buy |
VEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.75 | Buy |
| 50-day SMA: | 49.24 | Sell |
| 200-day SMA: | 46.57 | Buy |
| 8-day EMA: | 48.72 | Buy |
| 20-day EMA: | 48.81 | Buy |
| 50-day EMA: | 48.79 | Buy |
| 200-day EMA: | 47.12 | Buy |
PRAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.63 | Buy |
| 20-day SMA: | 52.17 | Buy |
| 50-day SMA: | 52.73 | Buy |
| 200-day SMA: | 30.62 | Buy |
| 8-day EMA: | 53.81 | Buy |
| 20-day EMA: | 52.95 | Buy |
| 50-day EMA: | 50.52 | Buy |
| 200-day EMA: | 38.45 | Buy |
Vanguard FTSE Developed Markets ETF Earnings Growth & VEA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.50 per share, a decrease next quarter of $0.25 per share, an increase this year of $11.19 per share, and a decrease next year of $1.42 per share.
Vanguard FTSE Developed Markets ETF Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Praxis Precision Medicines Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||